Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

18 Apr, 2019, 14:30 BST TAU BIO-LOGIC Announces Humanization of Picomolar Affinity Monoclonal Antibody Targeting TauC3 Protein for the Treatment of Alzheimer's Disease and Progressive Supranuclear Palsy

TAU BIO-LOGIC CORP. announced today that in collaboration with the UK-based group LifeArc, it has successfully humanized a monoclonal antibody...


18 Apr, 2019, 08:35 BST Cantargia Phase I Clinical Results on the Antibody CAN04 Selected for Oral Presentation at ASCO

Cantargia AB today announce that the phase I clinical data generated by the antibody CAN04 will be presented orally at the 2019 Annual ASCO meeting...


17 Apr, 2019, 14:00 BST Widespread Clinical Studies Can Reinvigorate the Legalization Movement for Cannabis

Researchers and scientists are constantly developing new, innovative medicines to effectively treat patients. However, the cost to conduct clinical...


17 Apr, 2019, 07:29 BST Alligator Bioscience AB (publ) Interim Report January-March 2019

Significant events January-March First patient dosed in Phase I clinical study of ATOR-1015. New preclinical data presented demonstrating strong...


16 Apr, 2019, 15:22 BST New Publication Validates Clinical Performance of Signatera for Recurrence Monitoring and MRD Assessment in Breast Cancer

Natera, Inc. (NASDAQ: NTRA), Cancer Research UK, Imperial College London and the University of Leicester, today announced the publication of results...


16 Apr, 2019, 08:30 BST AMO Pharma Announces Launch of First Clinician-Completed Rating Scale for Congenital Myotonic Dystrophy Type 1

AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, childhood onset neurogenetic disorders with limited...


15 Apr, 2019, 09:00 BST Norgine: New Real World Study Shows Rifaximin-a Significantly Reduced Hospitalisation in Patients With Overt Hepatic Encephalopathy (HE) When Added to Lactulose

Norgine B.V. today highlighted results of a real world study showing significant reductions in the number and length of hospitalisations when...


11 Apr, 2019, 19:12 BST InDex Pharmaceuticals Provides Status Update on the Patient Recruitment in the CONDUCT Study

InDex Pharmaceuticals Holding AB (publ) today announced that 197 patients, of the total 215 planned, have been enrolled to date in the CONDUCT study...


11 Apr, 2019, 13:30 BST Why International Regulations on Clinical Trials can Actually Reduce Costs and Shorten Time to Market

Every business or industry strives to improve quality, reduce costs and improve their products time to market. This, surprisingly, is true for the...


11 Apr, 2019, 12:49 BST LumiThera Announces First Patient Enrollment in the European Multi-Center, LIGHTSITE II Clinical Study to Treat Dry Age-Related Macular Degeneration

LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and disease, today...


11 Apr, 2019, 12:00 BST Completion of the First Interventional Phase-II Trial in the Innovative Medicines Initiative's New Drugs 4 Bad Bugs Programme

The Innovative Medicines Initiative (IMI)-funded COMBACTE-NET (Combatting Bacterial Resistance in Europe) consortium has completed the SAATELLITE...


11 Apr, 2019, 08:00 BST GenePOC Obtains CE Marked for Its GenePOC™ Carba Test

GenePOC Inc., member of the Debiopharm Group, announces its third test to be CE marked, the GenePOC Carba assay, to be used with the revogene™ device....


10 Apr, 2019, 09:53 BST Alligator Bioscience to Present New Preclinical Data on ATOR-1015 at PEGS Boston

Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that Chief Medical Officer Charlotte Russell, MD, PhD, will give an oral presentation ...


10 Apr, 2019, 08:50 BST New study exposes need for better management of anaemia

A large study just published in the journal Anaesthesia raises important questions about the way anaemia is currently managed in surgical patients...


10 Apr, 2019, 06:24 BST Nordic Nanovector: Safety Review Committee Approves Advancing to Final Dosing Regimen in Phase 1 Trial of Betalutin® in DLBCL

Nordic Nanovector ASA (OSE: NANO) announces that the Safety Review Committee (SRC) for the ongoing LYMRIT 37-05 clinical trial of...


09 Apr, 2019, 16:35 BST Through Pioneering Clinical Research, Institute of Life IVF Center in Greece and Embryotools in Spain Achieve Global Innovation in Assisted Reproduction

The birth of the first healthy baby through the pioneering Maternal Spindle Transfer method – implemented for the first time by the Institute of Life ...


09 Apr, 2019, 13:30 BST Biotech Brief: Growing Number of Ongoing Clinical Trials for Leukemia (AML) Brings New Hope

In the last few years the number of clinical trials looking for new treatments for Leukemia (AML) has continued to grow. In 2017, a report from...


09 Apr, 2019, 12:00 BST Alkermes Announces Positive Topline Results From Innovative Study of ARISTADA® and INVEGA SUSTENNA® for the Treatment of Schizophrenia

Alkermes plc (Nasdaq: ALKS) today announced positive topline results from ALPINE (Aripiprazole Lauroxil and Paliperidone palmitate: INitiation...


09 Apr, 2019, 09:02 BST Alvogen and Business Partners Obtain First European Approvals for Generic Ulipristal 5mg

Alvogen today announced that it has successfully concluded sixteen parallel registration procedures for Ulipristal tablets. Alvogen and its business...


09 Apr, 2019, 09:00 BST Enesi Pharma and University of Oxford Collaborate to Target Plague With a Novel ImplaVax®-enabled Adenovirus-based Solid Dose Vaccine

Enesi Pharma ("Enesi"), an innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products and scientists at...


09 Apr, 2019, 06:00 BST Pharming Group Announces Completion of Minority Investment in BioConnection BV

Highlights: Pharming takes a significant minority stake in BioConnection BV, its world class fill & finish partner Pharming has acquired its...


08 Apr, 2019, 12:15 BST The Brain Protection Company Announces Publication Of Manuscript By European Heart Journal Showing Carotid Pulse Intensity Powerfully Predicts Cognitive Decline

The Brain Protection Company Pty Ltd, a privately-held medical device company developing novel therapies and diagnostics for age-related...


08 Apr, 2019, 10:02 BST Clinical Trial Investigates Orbsen Therapeutics' ORBCEL-C™ Immunotherapy as Treatment for Two Autoimmune Liver Diseases

Orbsen Therapeutics, a biotechnology company focused on the development and commercialization of first-in-class stromal cell immunotherapies,...


08 Apr, 2019, 09:00 BST Galderma Marks Rosacea Awareness Month With New Insights Into Why Some Patients Are Self-treating and Launches Social Media Campaign to Reinforce Hidden Impact of the Disease

Building on the expert-authored report Rosacea: Beyond the visible, which highlighted the true extent of the psychosocial burden of rosacea globally, ...


06 Apr, 2019, 18:08 BST Positive Treatment Results for Buvidal® in Fentanyl Users Presented at the ASAM 50th Annual Conference

Camurus announces positive post-hoc analyses results from the randomized, double-blind, double-dummy Phase 3 study of CAM2038 (Buvidal®,...